comparemela.com

Latest Breaking News On - Parexel - Page 1 : comparemela.com

Parexel Appoints Susan R Salka to Board of Directors

Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiativesDURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Susan R. Salka, retired Chief Executive Officer and President

While Auto vs Allo Cell Therapy Debate Continues, VCs Look for Next Shiny Thing

Allogeneic cell therapy hasn’t caught up to autologous cell therapy yet, and the disappointing data so far has soured the entire allogeneic field for at least one venture capitalist. The cell therapy debate was one of the topics covered during a panel discussion at the Biopharm America conference.

CRO Market Shows Signs of Consolidation Amidst Record Levels of Demand and Growth

The market for CROs, once only niche providers of trial support services, is at an all-time high as sponsors increasingly outsource their clinical trial activities, leading to record levels of CRO consolidation and growth, according to a new analysis.

Parexel appoints Peyton Howell as Chief Operating and Growth Officer

Parexel, n-Lorem Foundation to support investigational therapies for nano-rare patients

Parexel to provide clinical operations, real-world data solutions and expertise including medical and regulatory alongside innovative clinical research tools

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.